* Eikon search string for individual stock moves: STXBZ
* The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
* The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock index futures rose slightly on Monday as investors
geared up for a busy week of corporate earnings, with results
from major companies including Facebook and Amazon on tap. .N
At 7:14 a.m. ET, Dow e-minis 1YMc1 were up 0.22% at
27,189. S&P 500 e-minis ESc1 were up 0.29% at 2,985.5, while
Nasdaq 100 e-minis NQc1 were up 0.47% at 7,879.75.
The top three NYSE percentage gainers premarket .PRPG.NQ :
** Washington Prime Group Inc WPG.N , up 7.1%
** Eros International PLC EROS.N , up 6.3%
** Pier 1 Imports Inc PIR.N , up 5.5%
The top NYSE percentage losers premarket .PRPL.NQ :
** Kinross Gold Corp KGC.N , down 6.7%
** Biohaven Pharmceutical Holding Co Ltd BHVN.N , down 6%
urn:newsml:reuters.com:*:nL4N24K41I
The top three Nasdaq percentage gainers premarket .PRPG.O :
** Taronis Technologies Inc TRNX.O , up 71.5%
** CUI Global Inc CUI.O , up 29.2%
** resTORbio Inc TORC.O , up 19.9%
The top three Nasdaq percentage losers premarket .PRPL.O :
** Safe-T Group Ltd SFET.O , down 10%
** Neuralstem Inc CUR.O , down 8.1%
** Co-Diagnostics Inc CODX.O , down 6.3%
** Biohaven Pharmaceutical Holding Co Ltd BHVN.N : down 6.0%
premarket
BUZZ-Shares fall on FDA rejection for ALS treatment
urn:newsml:reuters.com:*:nL4N24K41I
** Inflarx NV IFRX.O : down 6.0% premarket
BUZZ-Falls as Baird 'skeptical' of skin disease drug trial
analysis urn:newsml:reuters.com:*:nL4N24N2B5
** Paysign Inc PAYS.O : down 5.7% premarket
BUZZ-Paysign Inc: BTIG cuts to sell, says company valuation
stretched urn:newsml:reuters.com:*:nL4N24N2AX
** Galapagos NV GLPG.O : up 3.9% premarket
BUZZ-Galapagos shares rise as SVB Leerink hikes PT by $50
urn:newsml:reuters.com:*:nL4N24N2C5
** Amneal Pharmaceuticals Inc AMRX.N : up 2.9% premarket
BUZZ-Least exposed to opioid, price fixing litigations - SVB
Leerink urn:newsml:reuters.com:*:nL4N24N2BV
(Compiled by Abhishek Manikandan in Bengaluru)
((Abhishek.Manikandan@thomsonreuters.com;))